台股 » 個股 » 生展 » 籌碼相關 » 券商分點績效 » 券商分點個股進出

生展

(8279)
  • 股價
    158.5
  • 漲跌
    ▼1.5
  • 漲幅
    -0.94%
  • 成交量
    10
  • 產業
    上櫃 生技醫療類股
  • 67人加入追蹤

    立即追蹤

  • 本地時間:13:30

     
生展 (8279)籌碼相關-元大-歸仁 券商分點個股進出
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效,來找出真正獲利的贏家所在券商分點,進而追蹤此贏家所操作的股票與軌跡。

元大-歸仁 券商分點個股進出

日期買進張數買進均價賣出張數賣出均價收盤價買賣超60日均量成交佔比 大量交易提示
2023/08/1700.000.1166.50166.50-0.125-0.53%
2023/08/140166.5000.00166.000260.02%
2023/08/090171.0000.00171.500270.04%
2023/07/270173.5000.00173.000340.01%
2023/07/240170.5000.00170.500390.01%
2023/07/210170.0000.00170.000400.01%
2023/07/190173.0000.00168.500420.01%
2023/06/290172.8000.00173.000520.02%
2023/06/120176.0000.00171.500530.02%
2023/06/0900.001183.00183.00-151-1.95%
2023/06/061187.9200.00188.501531.92%
2023/05/180183.5000.00183.500600.02%
2023/05/160185.0000.00180.500600.01%
2023/05/1100.000.1180.00178.50-0.160-0.09%
2023/05/020.1188.4600.00185.000.1550.10%
2023/04/270184.5000.00188.000530.01%
2023/04/210176.5000.00180.000490.02%
2023/04/190183.5000.00183.500490.04%
2023/03/210167.0000.00164.500590.02%
2023/03/0100.001167.00168.50-157-1.74%
2023/02/231170.0000.00166.001581.72%
2022/09/1500.001163.00165.00-1100-1.00%
2022/09/0600.000.1167.50168.00-0.195-0.10%
2021/12/0300.002110.00109.00-220-9.80%
2021/08/2500.00190.3090.40-141-2.39%
2021/08/19188.9000.0089.901422.37%
2021/07/121104.0000.00104.501382.60%
2021/06/111105.0000.00106.001382.57%
2021/05/1400.000103.50103.00043-0.01%
2021/03/240115.0000.00116.000540.01%
2020/12/2200.000.1108.00108.00-0.130-0.33%
2020/12/2100.000.1107.50110.00-0.131-0.22%
2020/12/0200.000111.00112.50039-0.08%
2020/09/0200.008120.56121.00-8127-6.27%
2020/09/0100.0021122.33122.00-21128-16.35%
2020/08/1910134.0000.00135.00101158.68%
2020/08/0719130.0800.00130.00199220.53%
2020/07/1600.004116.50119.50-475-5.27%
2020/06/1900.001114.50113.50-164-1.55%
2020/06/171112.0000.00113.001641.54%
2020/05/262110.5000.00110.002922.16%
2020/04/2100.00194.7093.90-193-1.07%
2020/02/1700.001110.00110.00-164-1.55%
2020/02/0400.001111.00109.00-162-1.59%
2020/01/101115.5000.00115.501631.58%
2019/11/281119.5000.00119.501661.51%
2019/11/252124.0000.00120.502663.02%
2019/11/041127.0000.00127.001631.57%
2019/08/0200.001148.50150.00-196-1.04%
2019/07/2900.001159.50159.50-186-1.16%
2019/07/2500.001153.00153.50-186-1.15%
2019/07/241151.0000.00150.501841.18%
2019/07/1600.001151.50154.50-172-1.38%
2019/07/0200.001140.50139.00-155-1.79%
2019/05/291118.0000.00118.001661.50%
2019/05/0200.001127.50127.00-163-1.57%
2019/04/1200.002119.00120.00-256-3.55%
2019/03/2100.002118.75118.00-245-4.37%
2019/03/141121.0000.00118.501422.33%
2019/03/113125.3300.00123.503397.66%
2019/02/2100.002102.50103.00-225-7.73%
2019/02/2000.006104.00103.00-625-23.36%
2019/02/1800.004105.50105.50-424-16.30%
2018/08/27198.9000.0099.501721.39%
2018/06/141146.0000.00146.0012810.35%
2018/06/121151.0000.00149.0012850.35%
2018/06/0500.002159.50153.50-2296-0.68%
2018/06/041155.001158.00156.5002970.00%
2018/05/251146.0000.00145.5012990.33%
2018/05/1400.001154.50155.00-1356-0.28%
2018/05/041158.0000.00157.5013640.27%
2018/05/0300.001166.00163.00-1367-0.27%
2018/04/301159.0000.00158.5013640.27%
2018/04/231174.001178.00172.0003640.00%
2018/04/1300.005152.00152.50-5333-1.50%
2018/04/095170.5000.00168.0053221.55%
2018/04/0200.001157.00160.50-1297-0.34%
2018/03/301153.5000.00151.0012820.35%
2018/03/2900.004145.88147.50-4270-1.48%
2018/03/223139.674144.25139.00-1267-0.37%
2018/03/212143.5000.00143.0022670.75%
2018/03/163142.0000.00141.5032761.08%
2018/03/1500.001140.50144.50-1278-0.36%
2018/03/141135.5000.00137.0012860.35%
2018/03/0200.001140.00141.00-1313-0.32%
2018/03/0100.001137.00138.00-1312-0.32%
2018/02/221133.0000.00133.0013140.32%
2018/02/211130.5000.00130.5013110.32%
2018/02/121136.0000.00136.0013010.33%
〈國光生展望〉子公司安特羅腸病毒三期臨床入尾聲 明年展開IPOAnue鉅亨-2023/12/26
〈國光生展望〉流感疫苗申請巴西藥證+破傷風切新市場 外銷業績拚成長Anue鉅亨-2023/12/26
〈聯合再生展望〉洪傳獻:TOPCon技術明年成主流 獲利表現佳Anue鉅亨-2023/10/16
生展 相關文章